Kelly Gebo
#147,694
Most Influential Person Now
American epidemiologist
Kelly Gebo's AcademicInfluence.com Rankings
Kelly Gebomedical Degrees
Medical
#3053
World Rank
#3504
Historical Rank
Epidemiology
#731
World Rank
#763
Historical Rank
Download Badge
Medical
Why Is Kelly Gebo Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kelly Anne Gebo is an American epidemiologist and infectious disease specialist. She was the inaugural Vice Provost for Education at Johns Hopkins University and served as the Chief Medical and Scientific Officer for the All of Us Research Program at the National Institutes of Health.
Kelly Gebo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013) (1190)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (2009) (1170)
- Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. (2008) (487)
- HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) (476)
- Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. (2012) (475)
- The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States (2006) (446)
- Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic (2002) (331)
- Racial and Gender Disparities in Receipt of Highly Active Antiretroviral Therapy Persist in a Multistate Sample of HIV Patients in 2001 (2005) (284)
- Role of liver biopsy in management of chronic hepatitis C: A systematic review (2002) (245)
- Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. (2015) (243)
- Late presentation for human immunodeficiency virus care in the United States and Canada. (2010) (215)
- Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. (2009) (200)
- HIV infection and older Americans: the public health perspective. (2012) (195)
- Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals (2008) (194)
- Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study (2013) (193)
- Neurosyphilis in a clinical cohort of HIV-1-infected patients (2008) (190)
- Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis (2013) (189)
- Contemporary costs of HIV healthcare in the HAART era (2010) (186)
- Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). (2007) (178)
- Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. (2006) (167)
- Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002 (2005) (163)
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review (2002) (153)
- Establishment, Retention, and Loss to Follow-Up in Outpatient HIV Care (2012) (146)
- The Economic Burden of Late Entry Into Medical Care for Patients With HIV Infection (2010) (136)
- Retention Among North American HIV-Infected Persons in Clinical Care, 2000–2008 (2013) (135)
- Costs of HIV medical care in the era of highly active antiretroviral therapy. (1999) (131)
- Treatment of chronic hepatitis C: A systematic review (2002) (126)
- Virologic and immunologic response to HAART, by age and regimen class (2010) (120)
- Early Outpatient Treatment for Covid-19 with Convalescent Plasma (2022) (120)
- Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. (1996) (117)
- Comparing different measures of retention in outpatient HIV care (2012) (116)
- Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States (2018) (115)
- Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016) (114)
- The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster Among HIV Patients in the Highly Active Antiretroviral Therapy Era (2005) (111)
- Hospitalizations for Metabolic Conditions, Opportunistic Infections, and Injection Drug Use Among HIV Patients: Trends Between 1996 and 2000 in 12 States (2005) (110)
- Health-related quality of life in HIV-infected patients: the role of substance use. (2008) (110)
- An Improvement in Virologic Response to Highly Active Antiretroviral Therapy in Clinical Practice From 1996 Through 2002 (2005) (108)
- U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008 (2012) (106)
- Trends in Reasons for Hospitalization in a Multisite United States Cohort of Persons Living With HIV, 2001–2008 (2012) (104)
- Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. (2009) (103)
- The Lifetime Medical Cost Savings From Preventing HIV in the United States (2015) (101)
- Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. (2013) (96)
- Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort (2003) (94)
- Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. (2008) (94)
- Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection. (2015) (91)
- The impact of illicit drug use and substance abuse treatment on adherence to HAART (2007) (89)
- Alcohol use among HIV‐infected persons in care: results of a multi‐site survey * (2008) (87)
- CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? (2010) (86)
- Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals (2008) (86)
- Workshop on HIV Infection and Aging: What Is Known and Future Research Directions (2008) (84)
- Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989–2012: a matched case–control study (2019) (83)
- Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. (2012) (81)
- Estimating the Potential Pool of HIV‐Infected Deceased Organ Donors in the United States (2011) (81)
- Impact of Age on Retention in Care and Viral Suppression (2015) (78)
- Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort (2006) (77)
- Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. (2019) (76)
- Hospitalization Rates in an Urban Cohort After the Introduction of Highly Active Antiretroviral Therapy (2001) (76)
- The "All of Us" Research Program. Reply. (2019) (71)
- Elite Controllers are Hospitalized More Often than Persons with Medically Controlled HIV (2014) (68)
- Rapid Communication Hospital and Outpatient Health Services Utilization Among HIV‐Infected Patients in Care in 1999 (2002) (67)
- The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression (2015) (66)
- Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003 (2006) (66)
- Does the Presence of a Current Psychiatric Disorder in AIDS Patients Affect the Initiation of Antiretroviral Treatment and Duration of Therapy? (2004) (65)
- HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers (2016) (65)
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. (2009) (64)
- Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network. (2015) (64)
- Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era (2012) (64)
- Retention in Care Is More Strongly Associated With Viral Suppression in HIV-Infected Patients With Lower Versus Higher CD4 Counts (2014) (63)
- A pilot study of peer review in residency training (1999) (63)
- Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. (2008) (62)
- Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. (2014) (62)
- HIV patients with psychiatric disorders are less likely to discontinue HAART (2009) (61)
- Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy (2003) (61)
- Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America (2017) (59)
- Patterns of Diagnoses in Hospital Admissions in a Multistate Cohort of HIV-Positive Adults in 2001 (2005) (58)
- HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use (2009) (57)
- Absolute CD4 Vs. CD4 Percentage for Predicting the Risk of Opportunistic Illness in HIV Infection (2004) (56)
- Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic. (2006) (55)
- Venous Thromboembolism in Patients With HIV/AIDS: A Case-Control Study (2008) (54)
- Inpatient Health Services Utilization Among HIV-Infected Adult Patients in Care 2002–2007 (2010) (51)
- Structures of care in the clinics of the HIV Research Network. (2008) (50)
- Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. (2013) (50)
- Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes (2013) (50)
- Pseudo-outbreak of Mycobacterium fortuitum on a Human Immunodeficiency Virus Ward: transient respiratory tract colonization from a contaminated ice machine. (2002) (49)
- Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy. (2019) (47)
- Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly. (2008) (44)
- The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth. (2016) (42)
- Disparities in Receipt of Antiretroviral Therapy Among HIV-infected Adults (2002–2008) (2012) (41)
- Health Insurance Coverage for Persons in HIV Care, 2006–2012 (2014) (41)
- A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort. (2008) (40)
- Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma (2021) (40)
- Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. (2008) (40)
- Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. (2012) (40)
- Retention in care and health outcomes of transgender persons living with HIV. (2013) (40)
- Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. (2019) (39)
- Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. (2011) (38)
- HIV-related medical service use by rural/urban residents: a multistate perspective (2011) (35)
- Implications for Patient Management (2006) (34)
- The All of Us Research Program: Data quality, utility, and diversity (2020) (34)
- Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
- Pregnancy incidence and outcomes in vertically and behaviorally HIV-infected youth. (2011) (33)
- Disparities in Antiretroviral Treatment: A Comparison of Behaviorally HIV-Infected Youth and Adults in the HIV Research Network (2011) (33)
- Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India. (2007) (32)
- The HIV and Aging Consensus Project Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV (2011) (31)
- HIV and Aging (2006) (30)
- High Rates of Primary Mycobacterium avium Complex and Pneumocystis jiroveci Prophylaxis in the United States (2005) (30)
- Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use. (2007) (30)
- Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIV (2014) (28)
- The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities. (2019) (28)
- Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site. (2012) (27)
- Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009 (2013) (27)
- Johns Hopkins University Bloomberg School of Public Health MPH Capstone Project (2005) (27)
- Thirty-day hospital readmission rate among adults living with HIV (2013) (26)
- Strong Agreement of Nationally Recommended Retention Measures from the Institute of Medicine and Department of Health and Human Services (2014) (25)
- Associations between outpatient and inpatient service use among persons with HIV infection: a positive or negative relationship? (2007) (25)
- Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelines (2010) (24)
- Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act. (2016) (24)
- Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIV (2015) (24)
- Impact of Patient Race on Patient Experiences of Access and Communication in HIV Care (2008) (23)
- HIV infection in the elderly (2004) (23)
- Changes in Advanced Immunosuppression and Detectable HIV Viremia Among Perinatally HIV-Infected Youth in the Multisite United States HIV Research Network. (2013) (23)
- The HIV Research Network: a unique opportunity for real time clinical utilization analysis in HIV. (2003) (23)
- Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States (2022) (22)
- The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities (2020) (22)
- Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern (2022) (22)
- Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers (2021) (22)
- Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. (2015) (22)
- Vancomycin Resistance, esp, and Strain Relatedness: a 1-Year Study of Enterococcal Bacteremia (2004) (22)
- Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study. (2009) (21)
- Prostatic tuberculosis in an HIV infected male. (2002) (20)
- High-Risk Prescription Opioid Use Among People Living With HIV (2018) (19)
- The impact of combined antiretroviral therapy on biologic false-positive rapid plasma reagin serologies in a longitudinal cohort of HIV-infected persons. (2013) (19)
- Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. (2001) (19)
- Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy (2005) (18)
- Brief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States (2015) (18)
- Factors Associated With Retention Among Non-Perinatally HIV-Infected Youth in the HIV Research Network. (2016) (18)
- Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999–2007 (2011) (18)
- Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004–2014 (2017) (17)
- Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020. (2021) (16)
- The Epidemiology, Treatment Patterns, and Costs of Cytomegalovirus Retinitis in the Post-HAART Era Among a National Managed-Care Population (2004) (16)
- HIV infection in older people (2009) (16)
- Schizophrenia, AIDS and the Decision to Prescribe HAART (2007) (16)
- Progress With the All of Us Research Program: Opening Access for Researchers. (2021) (15)
- Hepatitis C Virus Testing in Adults Living with HIV: A Need for Improved Screening Efforts (2014) (15)
- Treatment of HIV infection in the older patient (2004) (15)
- Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities (2016) (15)
- Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000–2005 (2011) (14)
- Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial (2022) (14)
- Conformity of pediatric/adolescent HIV clinics to the patient-centered medical home care model. (2013) (13)
- Gonorrhoea and chlamydia in persons with HIV: number needed to screen (2019) (13)
- Predicting HIV care costs using CD4 counts from clinical trials. (2007) (12)
- HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014–2015 (2019) (12)
- Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study. (2019) (12)
- Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. (2011) (12)
- Trends in Hospitalizations Among Children and Young Adults with Perinatally Acquired HIV (2014) (12)
- Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers (2021) (12)
- Uptake and virological outcomes of single‐ versus multi‐tablet antiretroviral regimens among treatment‐naïve youth in the HIV Research Network (2019) (12)
- One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States (2018) (11)
- Predictive Analytics for Glaucoma using Data from the All of Us Research Program. (2021) (10)
- Multimorbidity Among Persons Living with HIV in the U.S. (2017) (10)
- Expenditures for Persons Living With HIV Enrolled in Medicaid, 2006–2010 (2016) (10)
- COVID-19 infections post-vaccination by HIV status in the United States (2021) (10)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- The shifting age distribution of people with HIV using antiretroviral therapy in the United States (2021) (9)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project (2021) (8)
- HIV viral suppression after transition from having no healthcare coverage and relying on Ryan White HIV/AIDS Program Support to Medicaid or private health insurance. (2019) (8)
- U.S. Hospitalization rates and reasons stratified by age among persons with HIV 2014–15 (2019) (8)
- Erratum: Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms (Clin Infect Dis (2009) 48 (816-21)) (2009) (8)
- Management of hepatitis C: a review of the NIH Consensus Development Conference. (2002) (7)
- Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020 (2021) (7)
- Hospital and Outpatient Health Services Utilization Among HIV-Infected Children in Care 2000–2001 (2005) (7)
- Role of liver biopsy in management of chronic hepatitis C: A systematic review (2002) (7)
- A medical student scholarly concentrations program: scholarly self-efficacy and impact on future research activities (2020) (7)
- Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection (2021) (7)
- HIV and hepatitis. (2003) (7)
- How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19? (2022) (7)
- Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US (2022) (6)
- Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection (2022) (6)
- Mpox in people with advanced HIV infection: a global case series (2023) (6)
- Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic (2021) (5)
- HIV and hepatitis C. (2002) (5)
- Management of chronic hepatitis C. (2002) (5)
- Public health studies as an undergraduate major. (2008) (5)
- The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox (2022) (5)
- Analysis of Clinical Outcomes of Pregnant Patients Treated With Nirmatrelvir and Ritonavir for Acute SARS-CoV-2 Infection (2022) (4)
- Heterogeneity in the costs of medical care among people living with HIV/AIDS in the United States. (2019) (4)
- Managing HIV infection in middle aged and older populations (2005) (4)
- HIV in patients over 50: an increasing problem. (2004) (4)
- Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19. (2023) (4)
- Cervical cancer epidemiology among HIV-infected women in North America (2010) (4)
- Herpes Zoster among Persons Living with HIV in the Current ART Era (2012) (3)
- Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort (2017) (3)
- Geographic Variation in Obesity at the State Level in the All of Us Research Program (2021) (3)
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review (2002) (3)
- Higher acuity resource utilization with older age and poorer HIV control in adolescents and young adults in the HIV Research Network. (2020) (3)
- Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. (2022) (3)
- Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States (2021) (3)
- Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research (2021) (3)
- Treatment of chronic hepatitis C: A systematic review (2002) (3)
- High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern (2022) (3)
- Increase in CD4 Count Among New Enrollees in HIV Care in the Modern Antiretroviral Therapy Era (2014) (3)
- On Academics: Public Health Studies as An Undergraduate Major (2008) (3)
- Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. (2021) (3)
- Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. (2021) (2)
- Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data (2017) (2)
- Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. (2020) (2)
- Epidemiology of atrial fibrillation in the All of Us Research Program (2021) (2)
- Pediatric data from the All of Us research program: demonstration of pediatric obesity over time. (2021) (2)
- Time Between Viral Loads for People With HIV During the COVID-19 Pandemic (2021) (2)
- Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts (2010) (2)
- CD4 T-lymphocyte percentages corresponding to CD4 T-lymphocyte count thresholds in a new staging system for HIV infection. (2014) (2)
- Track C Epidemiology and Prevention Science (2012) (1)
- 48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic (2021) (1)
- Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV (2023) (1)
- Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. (2023) (1)
- Liver biopsy and screening for cancer in hepatitis C. (2003) (1)
- Fitbit "Bring Your Own Device" data in the All of Us Research Program (2020) (1)
- 2520. Resource utilization in adolescents and young adults with HIV in the HIV Research Network (2019) (1)
- 1906. Hospitalization Rates Among Persons With HIV Who Gained Medicaid or Private Insurance in 2014 (2018) (1)
- An Overview of Cancer in the First 315,000 All of Us Participants (2022) (1)
- Patterns of Use and Outcomes in Patients Treated with Etravirine in the HIV Research Network (2013) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD. (2021) (1)
- 126. Falling Out of Care in Early Adulthood: Factors Associated With Loss to Follow-Up in HIV Research Network Youth After Age 21 (2013) (1)
- Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial. (2023) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- Absence of pathogenic viruses in COVID‐19 convalescent plasma (2022) (1)
- Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America. (2021) (1)
- Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort (2022) (1)
- The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum (2022) (1)
- 444. County-level COVID-19 Case Fatality Rate in Medicaid Expansion States Compared to Non-Expansion States (2021) (0)
- Brief Report: Hospitalization Rates Among Persons With HIV Who Gained Medicaid or Private Insurance After the Affordable Care Act in 2014 (2021) (0)
- Reply to Author Steele, et al. (2023) (0)
- Oral history of Kelly Gebo (1999) (0)
- Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD (2021) (0)
- TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
- Uptake and Virologic Outcomes of One-pill versus Multi-pill Antiretroviral Therapy Among Treatment-naïve Non-perinatally HIV-infected Youth (2006-2014) (2016) (0)
- Achieving a Representative Sample of Asian Americans in Biomedical Research Through Community-Based Approaches: Comparing Demographic Data in the All of Us Research Program With the American Community Survey (2022) (0)
- Management of Chronic Hepatitis C: Summary (2002) (0)
- Presenting CD4-Cell Count Is Rising, but Slowly (2013) (0)
- A growing number of men who have sex with men aging with HIV (2021-2031): a comparison of two microsimulation models. (2022) (0)
- Correspondence (2003) (0)
- Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Hepatitis: glimpses of optimism tempered by sobering mortality statistics. (2004) (0)
- Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Viral hepatitis co-infection in HIV. (2007) (0)
- Reply to Holtzman and Gallagher (2012) (0)
- Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence (2022) (0)
- Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment (2022) (0)
- 2845. Oral Antibiotic Use and Risk of Colorectal Cancer in the UK, 1989–2012: A Matched Case–Control Study (2019) (0)
- HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group the on and Aging (2018) (0)
- Title: Time Between Viral Loads for People with HIV during the COVID-19 Pandemic (2021) (0)
- 585. Hospitalization Rates and Diagnoses Vary by Age Group Among Persons with HIV (PWH) in 2014–2015 (2018) (0)
- Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations (2023) (0)
- Convalescent Plasma for Covid-19. Reply. (2022) (0)
- Discontinuity in Medicaid Coverage Among Young Adults with HIV. (2019) (0)
- Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. (2023) (0)
- Designing an electronic medical record alert to identify hospitalised patients with HIV: successes and challenges (2022) (0)
- Clinical pathological conference: A 60-year-old woman with brain lesions (2001) (0)
- COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample. (2023) (0)
- Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey. (2023) (0)
- Resource utilization across the continuum of HIV care: An emergency department-based cohort study. (2020) (0)
- Interview with Kelly Gebo, August 31, 1999 (2015) (0)
- P2.069* Factors Associated with Biologic False Positive Rapid Plasma Reagin (RPR) Serologies in HIV-1-Infected Persons (2013) (0)
- TO SCREEN OR NOT TO SCREEN FOR HEPATOCELLULAR CARCINOMA, THAT IS THE QUESTION (2003) (0)
- Viral hepatitis treatment and beyond: a review of CROI 2005. (2005) (0)
- Early Treatment, Inflammation and Post-COVID Conditions (2023) (0)
- Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout. (2023) (0)
- Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation (2022) (0)
- An Inpatient HIV Support Nurse to Promote Engagement in Outpatient HIV Care (2019) (0)
- The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017 (2022) (0)
- Contents page (1995) (0)
- Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. (2021) (0)
This paper list is powered by the following services:
Other Resources About Kelly Gebo
What Schools Are Affiliated With Kelly Gebo?
Kelly Gebo is affiliated with the following schools:
